|
CN1072649C
(zh)
|
1995-09-13 |
2001-10-10 |
武田药品工业株式会社 |
苯并氧杂吖庚因化合物,其生产方法和用途
|
|
US6432947B1
(en)
|
1997-02-19 |
2002-08-13 |
Berlex Laboratories, Inc. |
N-heterocyclic derivatives as NOS inhibitors
|
|
AU2610899A
(en)
|
1998-02-27 |
1999-09-15 |
Novo Nordisk A/S |
N-terminally modified glp-1 derivatives
|
|
EP1137667B1
(en)
|
1998-12-07 |
2004-11-17 |
Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. |
Analogues of glp-1
|
|
CN1364167A
(zh)
|
1999-02-26 |
2002-08-14 |
阿瑞那制药公司 |
G蛋白偶联受体6的小分子调节剂
|
|
AR035016A1
(es)
|
1999-08-25 |
2004-04-14 |
Takeda Chemical Industries Ltd |
Composicion de azol promotor de produccion/secrecion de neurotrofina, compuesto prodroga del mismo, composicion farmaceutica que lo comprende y uso del mismo para preparar esta ultima.
|
|
EP1235618A2
(en)
|
1999-09-07 |
2002-09-04 |
Conjuchem, Inc. |
Bioconjugation in vivo to pulmonary or blood components
|
|
EP1302462A4
(en)
|
2000-07-17 |
2007-07-18 |
Takeda Pharmaceutical |
SULFONATE DERIVATIVES, PROCESS FOR PRODUCTION AND USE THEREOF
|
|
BR0315815A
(pt)
|
2002-11-01 |
2005-09-13 |
Takeda Pharmaceutical |
Agentes para prevenir ou tratar neuropatia, para promover a produção ou a secreção de um fator neurotrópico, para melhorar a dor, neuroprotetor e farmacêutico, composto, métodos para prevenir ou tratar neuropatia e para promover a produção ou a secreção de um fator neurotrópico, para melhorar a dor para proteger um nervo em um mamìfero e para produzir um composto e uso de um composto
|
|
AU2003277576A1
(en)
|
2002-11-08 |
2004-06-07 |
Takeda Pharmaceutical Company Limited |
Receptor function controlling agent
|
|
US20070004736A1
(en)
|
2002-11-22 |
2007-01-04 |
Keiji Kubo |
Imidazole derivative, process for producing the same, and use
|
|
WO2004067548A2
(en)
|
2003-01-31 |
2004-08-12 |
Theratechnologies Inc. |
Chemically modified metabolites of regulatory peptides and methods of producing and using same
|
|
US7820837B2
(en)
|
2003-05-30 |
2010-10-26 |
Takeda Pharmaceutical Company Limited |
Condensed ring compound
|
|
EP1670515A2
(en)
|
2003-09-19 |
2006-06-21 |
Novo Nordisk A/S |
Albumin-binding derivatives of therapeutic peptides
|
|
EP1669352A4
(en)
|
2003-09-30 |
2008-12-17 |
Takeda Pharmaceutical |
THIAZOLINE DERIVATIVE AND ITS USE
|
|
GB0325644D0
(en)
|
2003-11-04 |
2003-12-10 |
Avidex Ltd |
Immuno ihibitory pyrazolone compounds
|
|
WO2005058823A1
(ja)
|
2003-12-17 |
2005-06-30 |
Takeda Pharmaceutical Company Limited |
ウレア誘導体、その製造法及び用途
|
|
US7456218B2
(en)
|
2003-12-25 |
2008-11-25 |
Takeda Pharmaceutical Company Limited |
3-(4-benzyloxyphenyl) propanoic acid derivatives
|
|
WO2005063725A1
(ja)
|
2003-12-26 |
2005-07-14 |
Takeda Pharmaceutical Company Limited |
フェニルプロパン酸誘導体
|
|
WO2005087710A1
(ja)
|
2004-03-15 |
2005-09-22 |
Takeda Pharmaceutical Company Limited |
アミノフェニルプロパン酸誘導体
|
|
JP4859665B2
(ja)
|
2004-03-30 |
2012-01-25 |
武田薬品工業株式会社 |
アルコキシフェニルプロパン酸誘導体
|
|
TWI396686B
(zh)
|
2004-05-21 |
2013-05-21 |
Takeda Pharmaceutical |
環狀醯胺衍生物、以及其製品和用法
|
|
US20060275288A1
(en)
|
2005-01-20 |
2006-12-07 |
Grihalde Nelson D |
GLP-1 receptor agonist and allosteric modulator monoclonal antibodies and uses thereof
|
|
US8957070B2
(en)
|
2005-04-20 |
2015-02-17 |
Takeda Pharmaceutical Company Limited |
Glucokinase activator compounds, methods of activating glucokinase and methods of treating diabetes and obesity
|
|
CA2607566A1
(en)
|
2005-05-06 |
2006-11-16 |
Bayer Pharmaceuticals Corporation |
Glucagon-like peptide 1 (glp-1) receptor agonists and their pharmacological methods of use
|
|
EP1916234B1
(en)
|
2005-07-29 |
2014-11-12 |
Takeda Pharmaceutical Company Limited |
Cyclopropanecarboxylic acid compound
|
|
US20090054435A1
(en)
|
2005-07-29 |
2009-02-26 |
Hiroshi Imoto |
Phenoxyalkanoic Acid Compound
|
|
JP4094660B1
(ja)
|
2005-08-10 |
2008-06-04 |
武田薬品工業株式会社 |
糖尿病治療剤
|
|
JP2007063225A
(ja)
|
2005-09-01 |
2007-03-15 |
Takeda Chem Ind Ltd |
イミダゾピリジン化合物
|
|
PE20071221A1
(es)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
|
|
AU2007265966B2
(en)
|
2006-06-27 |
2012-05-17 |
Takeda Pharmaceutical Company Limited |
Fused cyclic compounds
|
|
JP5399244B2
(ja)
|
2006-08-17 |
2014-01-29 |
アミリン・ファーマシューティカルズ,リミテッド・ライアビリティ・カンパニー |
選択可能な特性を持つdpp−iv耐性gipハイブリッドポリペプチド
|
|
EP2298772A1
(en)
|
2006-10-18 |
2011-03-23 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compounds
|
|
CN101573357B
(zh)
|
2006-10-19 |
2013-01-23 |
武田药品工业株式会社 |
吲哚化合物
|
|
WO2008093639A1
(ja)
|
2007-01-29 |
2008-08-07 |
Takeda Pharmaceutical Company Limited |
ピラゾール化合物
|
|
AU2008215490A1
(en)
|
2007-02-09 |
2008-08-21 |
Takeda Pharmaceutical Company Limited |
Fused ring compounds as partial agonists of PPAR-gamma
|
|
JPWO2008136428A1
(ja)
|
2007-04-27 |
2010-07-29 |
武田薬品工業株式会社 |
含窒素5員複素環化合物
|
|
EP2157859A4
(en)
|
2007-06-19 |
2011-01-12 |
Takeda Pharmaceutical |
INDAZOL COMPOUNDS FOR THE ACTIVATION OF GLUCCOKINASE
|
|
HUE032284T2
(en)
|
2008-03-18 |
2017-09-28 |
Novo Nordisk As |
Protease-stabilized, acylated insulin analogues
|
|
ES2558842T3
(es)
|
2008-06-17 |
2016-02-09 |
Indiana University Research And Technology Corporation |
Agonistas mixtos a base de GIP para el tratamiento de trastornos metabólicos y obesidad
|
|
TW201006821A
(en)
|
2008-07-16 |
2010-02-16 |
Bristol Myers Squibb Co |
Pyridone and pyridazone analogues as GPR119 modulators
|
|
US20120148586A1
(en)
|
2009-08-27 |
2012-06-14 |
Joyce Ching Tsu Chou |
Glucagon-like protein-1 receptor (glp-1r) agonists for treating autoimmune disorders
|
|
US8426414B2
(en)
|
2009-10-09 |
2013-04-23 |
Bristol-Myers Squibb Company |
Modulators of G protein-coupled receptor 88
|
|
KR20120123443A
(ko)
|
2010-01-27 |
2012-11-08 |
인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 |
대사 장애 및 비만 치료용 글루카곤 길항제-gip 항진제 콘쥬게이트
|
|
CN103221404B
(zh)
|
2010-05-13 |
2015-12-16 |
安姆根有限公司 |
可用作pde10抑制剂的不饱和氮杂环化合物
|
|
US20120021979A1
(en)
|
2010-06-24 |
2012-01-26 |
Vanderbilt University |
GLP-1 receptor modulation of addiction, neuropsychiatric disorders and erectile dysfunction
|
|
RU2013133803A
(ru)
|
2010-12-22 |
2015-01-27 |
Маркадиа Байотек, Инк. |
Способы лечения метаболических нарушений и ожирения при помощи пептидов на основе глюкагона, активных по отношению к рецепторам гип и гпп
|
|
CA3134906A1
(en)
|
2011-05-18 |
2012-11-22 |
Mederis Diabetes, Llc |
Improved peptide pharmaceuticals for insulin resistance
|
|
KR102002783B1
(ko)
|
2011-06-10 |
2019-07-24 |
베이징 한미 파마슈티컬 컴퍼니 리미티드 |
포도당 의존성 인슐리노트로핀 폴리펩타이드 유사물질, 이의 약학적 조성물 및 응용
|
|
US20150087586A1
(en)
|
2012-03-29 |
2015-03-26 |
Cebix, Inc. |
Pegylated c-peptide
|
|
CN104884056A
(zh)
|
2012-11-12 |
2015-09-02 |
雷德伍德生物科技股份有限公司 |
用于制备缀合物的化合物和方法
|
|
JP6548579B2
(ja)
|
2012-12-06 |
2019-07-24 |
ヴィクトリア リンク リミテッド |
コンジュゲート化合物
|
|
US9766239B2
(en)
|
2013-03-13 |
2017-09-19 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Synbodies for detection of human norovirus
|
|
CN105555756B
(zh)
|
2013-06-28 |
2018-12-07 |
奥克兰联合服务有限公司 |
氨基酸缀合物和肽缀合物及缀合方法
|
|
WO2015031268A1
(en)
|
2013-08-26 |
2015-03-05 |
Arizona Board Of Regents On Behalf Of Arizona State University |
High affinity synbodies for influenza
|
|
GB2528436A
(en)
|
2014-07-15 |
2016-01-27 |
Lancaster Univ Business Entpr Ltd |
Treatment of neurological diseases
|
|
CN108271356A
(zh)
*
|
2014-09-24 |
2018-07-10 |
印第安纳大学研究及科技有限公司 |
肠降血糖素-胰岛素缀合物
|
|
EP3218414A1
(en)
|
2014-11-14 |
2017-09-20 |
Angiochem Inc. |
Conjugates including an antibody moiety, a polypeptide that traverses the blood-brain barrier, and a cytotoxin
|
|
AR103242A1
(es)
|
2015-01-09 |
2017-04-26 |
Lilly Co Eli |
Compuestos co-agonistas de gip y glp-1
|
|
WO2016131893A1
(en)
|
2015-02-18 |
2016-08-25 |
Medimmune Limited |
Incretin fusion polypeptides
|
|
TWI622596B
(zh)
|
2015-10-26 |
2018-05-01 |
美國禮來大藥廠 |
升糖素受體促效劑
|
|
GB2551945B
(en)
|
2015-12-18 |
2021-09-08 |
Heptares Therapeutics Ltd |
Novel GLP-1 receptor agonist peptides
|
|
GB201620611D0
(en)
|
2016-12-05 |
2017-01-18 |
Univ Of Lancaster |
Treatment of neurological diseases
|
|
MX2020009950A
(es)
*
|
2018-03-23 |
2021-04-28 |
Carmot Therapeutics Inc |
Moduladores de receptores acoplados a proteina g.
|
|
TWI799680B
(zh)
|
2019-01-29 |
2023-04-21 |
美商美國禮來大藥廠 |
製備gip/glp1雙重促效劑之方法
|
|
CN110684082B
(zh)
|
2019-10-08 |
2021-12-10 |
江苏诺泰澳赛诺生物制药股份有限公司 |
Gip和glp-1双激动多肽化合物及药学上可接受的盐与用途
|
|
TW202216746A
(zh)
|
2020-06-22 |
2022-05-01 |
印度商太陽製藥工業有限公司 |
長效型glp-1/gip雙重促效劑
|
|
KR20220050820A
(ko)
|
2020-10-16 |
2022-04-25 |
한미약품 주식회사 |
Glp-1/gip 이중작용제, 이의 지속형 결합체, 및 이를 포함하는 약학적 조성물
|
|
CN116171164A
(zh)
|
2020-10-17 |
2023-05-26 |
太阳医药工业有限公司 |
Glp-1/gip双重激动剂
|
|
CN114617956B
(zh)
|
2020-12-10 |
2023-10-03 |
江苏中新医药有限公司 |
一种高效降糖的蛋白质药物
|
|
CN116635050A
(zh)
|
2020-12-24 |
2023-08-22 |
韩美药品株式会社 |
对胰高血糖素、glp-1和gip受体全部具有活性的新型三重激动剂及其用途
|
|
KR20240007251A
(ko)
*
|
2021-05-13 |
2024-01-16 |
카모트 테라퓨틱스, 인크. |
G-단백질 결합 수용체의 조절제
|
|
IL310644A
(en)
|
2021-08-23 |
2024-04-01 |
Lilly Co Eli |
Compounds and Methods for Liquid Phase Synthesis
|
|
EP4410827A4
(en)
|
2021-09-02 |
2026-04-29 |
Sunshine Lake Pharma Co Ltd |
GLP-1/GIP Dual Target Fusion Polypeptide and Protein and Their Applications
|
|
EP4436991A1
(en)
|
2021-11-22 |
2024-10-02 |
Sun Pharmaceutical Industries Limited |
Process for the preparation of tirzepatide or pharmaceutically acceptable salt thereof
|